NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
school
University Rankings
subject
University Subject Rankings
insights
Subject Rankings
place
Country Rankings
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Ahmad İskandarani
Hamad Medical Corporation - / Qatar
Others
AD Scientific Index ID: 4886907
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Ahmad İskandarani's MOST POPULAR ARTICLES
1-)
Accelerated lipid catabolism and autophagy are cancer survival mechanisms under inhibited glutaminolysisA Halama, M Kulinski, SS Dib, SB Zaghlool, KS Siveen, A Iskandarani, ...Cancer Letters 430, 133-147, 2018492018
2-)
Anticancer activity of camel milk via induction of autophagic death in human colorectal and breast cancer cellsR Krishnankutty, A Iskandarani, L Therachiyil, S Uddin, F Azizi, M Kulinski, ...Asian Pacific journal of cancer prevention: APJCP 19 (12), 3501, 2018392018
3-)
Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cellsKS Prabhu, KS Siveen, S Kuttikrishnan, A Iskandarani, M Tsakou, ...PLoS One 12 (7), e0180895, 2017382017
4-)
Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alphaRM El Eit, AN Iskandarani, JL Saliba, MN Jabbour, RA Mahfouz, ...International Journal of Cancer 134 (4), 988-996, 2014352014
5-)
Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cellsA Iskandarani, AA Bhat, KS Siveen, KS Prabhu, S Kuttikrishnan, MA Khan, ...Journal of Translational Medicine 14, 1-12, 2016302016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept